Related Experiment Video
Updated: Jul 20, 2026

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
Published on: February 7, 2014
Blood pressure as a predictor of cardiovascular events in the elderly: the William Hale Research Program
S C Masley1, S E Phillips, D D Schocken
1Carillon Executive Health, St Anthony's Health Care, St Petersburg, FL, USA. steven.masley@baycare.org
Insights
Elevated systolic blood pressure (SBP) significantly increases cardiovascular disease (CVD) risk in older adults. Diastolic blood pressure (DBP) risk varies by age, with 80-90 mm Hg optimal for those 75 and older.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Public Health
Background:
- Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in the elderly.
- Understanding the precise role of blood pressure (BP) in CVD risk stratification in this demographic is crucial for effective prevention strategies.
Purpose of the Study:
- To evaluate the association between systolic blood pressure (SBP) and diastolic blood pressure (DBP) and the risk of future cardiovascular events in individuals over 64 years of age.
- To determine if age modifies the relationship between BP categories and CVD risk.
Main Methods:
- A prospective cohort study of 4,008 elderly patients (>64 years) followed for a median of 11.1 years.
- Blood pressure categorized, and cardiovascular events (myocardial infarction, stroke, CVD death) ascertained.
- Cox proportional hazard ratios adjusted for weight, gender, smoking, and alcohol use, with separate analyses for age groups (<75 and >=75 years).
Main Results:
- Elevated SBP is a strong, linear, and graded predictor of future CVD events across all ages studied (P<0.0001).
- The lowest CVD event frequency occurred with SBP <120 mm Hg.
- In individuals <75 years, DBP elevation was not a significant CVD risk factor. In those >=75 years, a DBP of 80 to <90 mm Hg showed the lowest significant risk (RR=0.59).
Conclusions:
- Findings support current guidelines for managing SBP in the elderly.
- Optimal DBP thresholds for CVD risk reduction may differ based on age, particularly for those >=75 years.
- Further research is needed to define precise DBP targets for different elderly age strata.
Abstract:
This study evaluates the association between blood pressure (BP) and the risk of developing cardiovascular disease (CVD) events in the elderly. The Morton Plant Mease Foundation has followed 4,008 elderly patients >64 years of age for at least 5 years. Systolic and diastolic blood pressure (SBP and DBP) was divided into categories. Cardiovascular disease events were classified as myocardial infarction, stroke, and CVD-related deaths reported from the National Death Index. Cox proportional hazard ratios were used to assess the relationship between BP and CVD events and controlled for weight, gender, smoker, and alcohol use. Ages <75 and >or=75 years were assessed separately. After 11.1 years of follow-up, elevated SBP (P=<0.0001) is strongly associated with developing a future CVD event; the relationship is linear and graded and holds for ages above and below 75 years. The frequency of CVD events was lowest in the SBP <120 mm Hg group. In subjects <75 years of age, DBP elevations were not a significant risk factor for CVD events. (relative risk (RR): DBP 70 to <80 mm Hg=0.92; DBP 80 to <90 mm Hg=0.88; DBP >or=90 mm Hg=1.02.) With subjects >or=75 years of age, a DBP between 80 and 90 is associated with the lowest significant risk for CVD (RR: DBP 70 to <80 mm Hg=0.74; DBP 80 to <90 mm Hg=0.59; DBP >or=90=0.71). In conclusion, these findings support the Joint National Committee on Hypertension recommendations for SBP in the elderly. Further studies are warranted to identify optimal DBP for the elderly at various ages.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Errors occurring during blood pressure monitoring
Several factors...
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension and Regulation of Blood Pressure
Measurement of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies

